Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (43)

« Back to Publications

Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areas.

Chamba C. et al, (2026), Nat Med

Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania.

Jiang J. et al, (2026), BMC Med

Optimising antibiotic “review and revise” in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial

Llewelyn MJ. et al, (2025), NIHR Journals Library

Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma

Chamba C. et al, (2025)

Rituximab for children with EBV-positive Burkitt lymphoma in East Africa.

Mawalla WF. et al, (2025), Blood Adv, 9, 2393 - 2401

Using liquid biopsy in early lung cancer diagnosis: a systematic review of health economic analyses and budget impact analysis for the UK NHS

Kew E. et al, (2025), Journal of Thoracic Oncology, 20

Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumour DNA: a Comparative Microcosting Study

MORRELL L. et al, (2025), Value in Health Regional Issues

Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC-Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa.

Chamba C. et al, (2025), JCO Glob Oncol, 11

THE RISE OF OPTIMIZATION IN NICE GUIDANCE: A TWO-DECADE REVIEW WITH A FOCUS ON PREVENTION

Barr-Keenan REA. and Morrell L., (2025), VALUE IN HEALTH, 28

THE RISE OF OPTIMIZATION IN NICE GUIDANCE: A TWO-DECADE REVIEW WITH A FOCUS ON PREVENTION Rachel EA Barr-Keenan, BDS (Hons), MFDS RCPSG (Glas)1

Barr-Keenan REA. and Morrell L., (2025), VALUE IN HEALTH, 28

"TELL ME A STORY": A RANDOMIZED STUDY COMPARING TABULATED AND NARRATIVE PRESENTATIONS OF A DISCRETE CHOICE EXPERIMENT

Morrell L. et al, (2025), VALUE IN HEALTH, 28

Using liquid biopsy in early lung cancer diagnosis: A systematic review of health economic analyses and budget impact analysis for the UK NHS

Kew E. et al, (2025), JOURNAL OF THORACIC ONCOLOGY, 20

Understanding micro costing a genomics-based diagnostic in a resource-limited setting: experiences and challenges from a Burkitt lymphoma study in sub-Saharan Africa

Ruhago GM. et al, (2024), Discover Health Systems, 3

How, why and when are delayed (back-up) antibiotic prescriptions used in primary care? A realist review integrating concepts of uncertainty in healthcare.

Mcleod M. et al, (2024), BMC Public Health, 24

Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use

ROOPE L. et al, (2024), Communications Medicine

Load More